We are live on ! Find out more
VAR

Varian Medical Systems, Inc.
VAR

Delisted

VAR was delisted on the 14th of April, 2021.

498 hedge funds and large institutions have $7.71B invested in Varian Medical Systems, Inc. in 2014 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 151 increasing their positions, 207 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 29

3% more funds holding

Funds holding: 485498 (+13)

1% less capital invested

Capital invested by funds: $7.8B → $7.71B (-$99.4M)

10% less funds holding in top 10

Funds holding in top 10: 109 (-1)

13% less call options, than puts

Call options by funds: $10.5M | Put options by funds: $12.1M

27% less repeat investments, than reductions

Existing positions increased: 151 | Existing positions reduced: 207

Holders
498
Holders Change
+13
Holders Change %
+2.68%
% of All Funds
14.31%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.26%
New
46
Increased
151
Reduced
207
Closed
29
Calls
$10.5M
Puts
$12.1M
Net Calls
-$1.58M
Net Calls Change
-$10.8M
Name Holding Trade Value Shares
Change
Change in
Stake
PI
126
Placemark Investments
Illinois
$8.28M +$381K +5,305 +5%
CBOA
127
Commonwealth Bank of Australia
Australia
$8.01M -$14.3M -199,681 -65%
HTI
128
Hikari Tsushin Inc
Japan
$7.7M
FNBOO
129
First National Bank of Omaha
Nebraska
$7.49M +$2.95K +41 +0%
FNT
130
First Nebraska Trust
Nebraska
$7.41M -$4.1K -57 -0.1%
GAM
131
Gotham Asset Management
New York
$7.36M +$4.1M +57,070 +130%
HA
132
Halsey Associates
Connecticut
$7.25M -$42.9K -597 -0.6%
VOYA Investment Management
133
VOYA Investment Management
Georgia
$7.04M -$179K -2,491 -3%
Barclays
134
Barclays
United Kingdom
$6.86M -$1.05M -14,630 -13%
NAP
135
New Amsterdam Partners
New York
$6.81M +$6.71M +93,347 New
DL
136
Delta Lloyd
Netherlands
$6.8M +$22.3K +311 +0.3%
TA
137
Teachers Advisors
New York
$6.65M -$48.2K -671 -0.7%
OAM
138
Oxford Asset Management
United Kingdom
$6.29M -$755K -10,508 -11%
BCIM
139
British Columbia Investment Management
British Columbia, Canada
$6.29M +$261K +3,630 +4%
SBCM
140
Schwerin Boyle Capital Management
Massachusetts
$6.24M
GH
141
GAM Holding
Switzerland
$6.02M
BPC
142
Banque Pictet & Cie
Switzerland
$5.92M +$5.83M +81,171 New
JA
143
JLB & Associates
Michigan
$5.9M +$186K +2,590 +3%
NIM
144
Needham Investment Management
New York
$5.82M
TA
145
TBP Advisors
New York
$5.81M -$123K -1,705 -2%
KeyBank National Association
146
KeyBank National Association
Ohio
$5.77M +$106K +1,482 +2%
WIC
147
Willis Investment Counsel
Georgia
$5.7M +$150K +2,093 +3%
Fidelity Investments
148
Fidelity Investments
Massachusetts
$5.54M -$4.77M -66,444 -47%
LAM
149
Lapides Asset Management
Connecticut
$5.37M
CCM
150
Chilton Capital Management
Texas
$5.34M -$477K -6,634 -8%

VAR Hedge Fund Activity: Q2 2014 in Review

498 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Varian Medical Systems, Inc. (VAR) for Q2 2014, worth a combined $7.71B — down 1.3% from $7.8B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new VAR positions and 29 closed out — a net gain of 17 holders — while 151 added to existing stakes and 207 trimmed.

The largest buyer was Norges Bank, adding an estimated $69.5M. The largest seller was Capital World Investors, cutting an estimated $101M.

  • 498 institutional investors held Varian Medical Systems, Inc. (VAR) as of Q2 2014, up from 485 in Q1 2014.
  • Funds reported $7.71B of Varian Medical Systems, Inc. stock for Q2 2014, down 1.3% quarter-over-quarter.
  • 46 funds opened new Varian Medical Systems, Inc. positions in Q2 2014 and 29 closed out, a net change of +17 holders.
  • The largest Varian Medical Systems, Inc. buyer in Q2 2014 was Norges Bank, an estimated $69.5M added.
  • The largest Varian Medical Systems, Inc. seller in Q2 2014 was Capital World Investors, an estimated $101M sold.

Based on aggregated 13F filings for Q2 2014.